To me it just sounds like the delay is caused by difficulties in getting the money out of China. Could it be that Kam Lung are reneging on the underwriting deal?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025